Presentation TCT 2016 Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial? Presenter: Ted Feldman, Allan Schwartz, JoAnn Lindenfeld October 30, 2016
Presentation TCT 2016 Epidemiology and Treatment of Primary and Secondary Mitral Regurgitation: Global Perspectives Presenter: Ted Feldman, Allan Schwartz, Ralph Stephan von Bardeleben October 30, 2016
Presentation TCT 2016 A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists Presenter: Ted Feldman, Allan Schwartz, Mark Reisman October 30, 2016
Presentation TCT 2016 My Rosy Prophecy: What Will the Specialty of Mitral Valve Therapeutics Look Like in 10 Years? Presenter: James S. Gammie, James B. Hermiller Jr., Alec S. Vahanian October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Surgical Mitral Valve Repair Or Replacement Via A Minimally Invasive Approach Will Be The Gold Standard! Presenter: James S. Gammie, James B. Hermiller Jr., Steven F. Bolling October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? No, The Bar Is Too High Transcatheter Mitral Repair Will Always Be Safer And Nearly As Effective! Presenter: James S. Gammie, James B. Hermiller Jr., Ted Feldman October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Transcatheter MV Replacement Will Become Standard Of Care For Secondary MR! Presenter: James S. Gammie, James B. Hermiller Jr., Stephan Windecker October 30, 2016
Presentation TCT 2016 First Debate: Should The Low Surgical Risk Patient With Degenerative MR Be Offered Mitraclip? Absolutely Not - In No Universe Would That Be Considered Acceptable Care! Presenter: James S. Gammie, James B. Hermiller Jr., Alfredo Trento October 30, 2016
Presentation TCT 2016 First Debate: Should the Low Surgical Risk Patient With Degenerative MR Be Offered Mitraclip? Absolutely! - As Long as He Receives Truly Informed Consent by A Heart Team! Presenter: James S. Gammie, James B. Hermiller Jr., Brian K. Whisenant October 30, 2016
Presentation TCT 2016 Germany Presents: How Did I Treat This Case Presenter: Dariusz Dudek, Petr Kala, Michael Haude October 30, 2016
Presentation TCT 2016 Czech Republic Responds: How Would I Treat This Case? Presenter: Dariusz Dudek, Petr Kala, Martin Mates October 30, 2016
Presentation TCT 2016 Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure? Presenter: Dariusz Dudek, Petr Kala, Michael Haude October 30, 2016
Presentation TCT 2016 From Surgical to Transcatheter Treatment of Tricuspid Regurgitation Presenter: Russell A. Brandwein October 30, 2016
Presentation TCT 2016 Poland Presents: How Did I Treat This Case? Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala October 30, 2016
Presentation TCT 2016 France Responds: How Would I Treat This Case? Presenter: Dariusz Dudek, Petr Kala, Patrick Ohlmann October 30, 2016
Presentation TCT 2016 Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure? Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala October 30, 2016
Presentation TCT 2016 Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)? Presenter: Dariusz Dudek, Petr Kala, Holger Thiele October 30, 2016
Presentation TCT 2016 Introduction and Session Objectives Presenter: Dariusz Dudek, Petr Kala October 30, 2016
Presentation TCT 2016 Czech Republic Presents: How Did I Treat This Case? Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny October 30, 2016
Presentation TCT 2016 Poland Responds: How Would I Treat This Case? Presenter: Eric Van Belle, Jochen Wöhrle, Marek Grygier October 30, 2016